Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

Clinical trial NCT04325217 · COMPLETED

Trial details

NCT number: NCT04325217
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Diseases, Interstitial

Start date: 2020-05-27
Primary completion: 2026-07-13
Enrollment: 586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.